Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03970642 · ClinicalTrials.gov registry record · NA

Video Directly Observed Therapy (VDOT) to Improve Medication Adherence

A NA study, sponsored by UConn Health.

Terminated
Registry status
NA
Development phase
35
Enrollment target

NCT03970642 is a NA study that was terminated before completion, run by UConn Health. The registered enrollment target is 35 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03970642, a NA study, was terminated before completion, sponsored by UConn Health.

TERMINATED
Registry status
NA
Development phase
35 participants
Enrollment target

Study Summary

Due to the lack of human resources, it is impossible to monitor patients' medication adherence objectively or in-person by observation like tuberculosis programs worldwide do. The feasibility and patient acceptance of the innovative video-based directly observed therapy (VDOT) approach for improving medication adherence among tuberculosis patients has been demonstrated through studies in the United States as well as internationally (7). Medication adherence among VDOT users has been found to be comparable to in-person directly observed treatment (91% vs 95%) among patients in New York (8). In this clinical research project, we will test the feasibility, acceptance and effectiveness of an innovative mobile-based behavioral intervention to improve medication adherence and depression symptoms among patients suffering from depression.

Interventions

  • OTHER Video directly observed therapy

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2019-05-27
Est. Completion 2020-04-15
Phase NA

Sponsor

UConn Health

178 total trials

What the Registry Record Tells You About NCT03970642

The ClinicalTrials.gov registry entry for NCT03970642 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Video directly observed therapy is the first listed.

NCT03970642 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03970642 about?

NCT03970642 is a clinical study titled "Video Directly Observed Therapy (VDOT) to Improve Medication Adherence". Due to the lack of human resources, it is impossible to monitor patients' medication adherence objectively or in-person by observation like tuberculosis programs worldwide do. The feasibility and patient acceptance of the innovative video-based directly observed therapy (VDOT) approach for improving...

What is the current status of trial NCT03970642?

This trial is currently terminated. It is a NA study. The enrollment target is 35 participants. The study started on 2019-05-27. Estimated completion is 2020-04-15.

What interventions are being tested in trial NCT03970642?

The interventions under investigation include: Video directly observed therapy (OTHER).

Who is sponsoring clinical trial NCT03970642?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.